Akur8

Akur8 is a venture-backed operating company, not an investment firm. Decision-making authority sits with co-founder and CEO Samuel Falmagne and the management board, which includes the CFO, COO, CTO, and Chief Client Officer. Strategic moves such as the Slope Software acquisition and the RSM partnership expansion reflect this operator-led governance model.

Akur8 operates as a venture-funded B2B SaaS company. It is not a family office. The firm raised capital from external investors to build its actuarial platform and has scaled through customer revenue and strategic acquisitions, most recently entering the life and annuity market via Slope Software.

Akur8 does not make fund commitments or deploy capital as an allocator. Its corporate strategy includes direct acquisitions—such as the purchase of Slope Software—and partnership agreements, like the expanded relationship with RSM. These are operational moves that extend its product suite and distribution, not financial investments.

Akur8 itself is not an investor. As a growth-stage Insurtech, it has been on the receiving end of venture funding. Its own deal activity—buying Slope Software—targets technology companies that can be integrated into its existing platform to accelerate geographic or product-line expansion.

Akur8 focuses exclusively on the insurance vertical, covering P&C, life, and pensions. It does not serve banking, capital markets, or other financial services segments, and it avoids general-purpose machine learning use cases outside regulated actuarial work.

Sales are direct via its offices in Paris, London, New York, and Tokyo, supplemented by a network of over 150 consulting partners that embed Akur8’s software into their client engagements. The firm also runs a content engine of white papers and executive interviews targeting actuarial and underwriting leaders.

Akur8 acquired Slope Software to enter the life and annuity insurance market, integrating Slope’s modeling capabilities into its end-to-end platform. The deal adds a dedicated life actuarial product line to Akur8’s existing P&C pricing and reserving modules, giving insurers a single vendor across the actuarial stack.